Latest Articles
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases | Newswise - Newswise
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases | Newswise Newswise
Published: Sept. 2, 2025, 11:05 p.m.
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases - Yale School of Medicine
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases Yale School of Medicine
Published: Sept. 2, 2025, 12:57 p.m.
BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer TipRanks
Published: Aug. 22, 2025, 4:17 p.m.
BioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer TipRanks
Published: Aug. 20, 2025, 4:07 p.m.
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers - TipRanks
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers TipRanks
Published: Aug. 20, 2025, 4:06 p.m.
Dysfunction of natural killer cells promotes immune escape and disease progression in endometriosis - Frontiers
Dysfunction of natural killer cells promotes immune escape and disease progression in endometriosis Frontiers
Published: Aug. 14, 2025, 3:57 p.m.
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials - Stock Titan
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials Stock Titan
Published: Aug. 6, 2025, 1 p.m.
CD276xCD3 bispecific antibody shows preclinical promise for the treatment of endometrial cancer - BioWorld MedTech
CD276xCD3 bispecific antibody shows preclinical promise for the treatment of endometrial cancer BioWorld MedTech
Published: Aug. 1, 2025, 1 p.m.
Activated eosinophil plays a role in promoting fibrosis in endometriotic lesion - Nature
Activated eosinophil plays a role in promoting fibrosis in endometriotic lesion Nature
Published: July 31, 2025, 9:03 p.m.
CIAPIN1 promotes survival, proliferation, migration and glycolysis of endometrial cancer cells through PI3K/Akt pathway - Nature
CIAPIN1 promotes survival, proliferation, migration and glycolysis of endometrial cancer cells through PI3K/Akt pathway Nature
Published: July 30, 2025, 1:56 a.m.
Link copied to clipboard!